Table 1. Trial omissions, locomotor activity and shock reactivity in the Risky Decision-Making Task in males and females.
Session | % Omitted Trials | Locomotion (locomotor units/ITI) | Shock reactivity (locomotor units/shock) |
---|---|---|---|
Risky Decision-Making Task with equal shock magnitude | |||
Male | 3.4 (1.9)* | 16.6 (1.7)* | 2.6 (0.2) |
Female | 15.2 (2.5)* | 11.3 (0.9)* | 2.3 (0.3) |
Risky Decision-Making Task with adjusted shocks | |||
Male | 0.3 (0.2)* | 18.6 (2.7) | N/A |
Female | 10.1 (4.1)* | 13.6 (2.5) | N/A |
Amphetamine | |||
Vehicle | |||
Male | 5.8 (4.5) | 17.5 (2.9) | 2.8 (0.3) |
Female | 18.0 (5.3) | 14.2 (1.8) | 2.1 (0.3) |
0.3 mg/kg | |||
Male | 4.5 (3.2)* | 21.2 (3.2) | 2.5 (0.3) |
Female | 16.3 (4.4)* | 17.2 (2.1) | 2.2 (0.4) |
1.0 mg/kg | |||
Male | 7.3 (3.6)* | 23.8 (2.9) | 2.5 (0.3)* |
Female | 31 (6.8)* | 24.7 (4.0) | 1.2 (0.3)* |
1.5 mg/kg | |||
Male | 14.8 (3.4)* | 25.8 (2.1) | 2.1 (0.4)* |
Female | 66.8 (9.4)* | 22.6 (2.4) | 0.3 (0.2)*† |
Asterisks indicate a significant difference between males and females.
A cross indicates a significant sex X dose interaction.